DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lavagna A, Bergallo M, Daperno M. et al.
Infliximab and the risk of latent viruses reactivation in active Crohn’s disease.
Iflamm Bowel Dis 2007;
13: 896-902
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.